Trends in the incidence of childhood type 1 diabetes after the COVID-19 lockdown in Finland: An observational study
PLOS Medicine · 02.11.2026 · 23 (11) · e1005288
DOI: 10.1371/journal.pmed.1005288 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift PLOS Medicine, online erschienen am 02.11.2026. Verfasst von Susanna Tall und 15 weiteren Autor:innen. Beteiligte Einrichtung: Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, COVID-19, Quarantine. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Helsingin ja Uudenmaan Sairaanhoitopiiri, Horizon 2020 Framework Programme, Academy of Finland.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
While COVID-19 lockdowns have been systematically associated with increased incidence rate of type 1 diabetes, less is known about the disease rates after lockdowns. We compared the incidence of type 1 diabetes after the COVID-19 pandemic-related closure of society (i) to the time when lockdown was implemented and to (ii) the time before the pandemic in Finland. Methods and findings The incidence of type 1 diabetes after the lockdown (09/2021–12/2022) was compared to the incidence during the lockdown (03/2020–08/2021) and before the lockdown (three 18-month terms 2014–2019) in Finnish children under the age of 15 years. Previous exposure to SARS-CoV-2 was identified by combining information on COVID-19 vaccination with data on SARS-CoV-2 antibodies analyzed in blood samples. The temporal cohort included 3,467 pediatric type 1 diabetes cases, distributed across post-lockdown ( n = 586), lockdown ( n = 785), and pre-pandemic ( n = 2,096) periods. The incidence of type 1 diabetes after the lockdown was significantly lower than the incidence during the lockdown [incidence rate ratio (IRR = 0.85; 95% Cl [0.77,0.95]; p = 0.004)]. The rate of type 1 diabetes after the lockdown did not significantly differ from the time before lockdown (IRR = 1.00; 95% Cl [0.91,1.09]; p = 0.932). The frequency of children testing positive for infection-associated SARS-CoV-2 antibodies increased from 0.9% during the lockdown to more than 40% after the lockdown. Study limitations include a relatively short follow-up period after the lockdown and the lack of explicit modeling of the underlying long-term secular trend in type 1 diabetes incidence.
Conclusions
The lockdown represents a peak in childhood type 1 diabetes incidence in Finland compared to both the pre-pandemic and post-lockdown periods. However, the reversion toward historical levels after the lockdown does not necessarily establish a return to the expected historical trajectory, nor can it fully distinguish a transient change from temporal compensation superimposed on the background secular trend. The contrasting patterns between type 1 diabetes incidence and SARS-CoV-2 antibody prevalence during and after the lockdown suggest an indirect rather than a direct role of the virus in triggering the observed changes in incidence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
- Department of Public Health, Finnish Institute for Health and Welfare, Helsinki, Finland.
- Pediatric Research Center, New Children's Hospital, Helsinki University Hospital, Helsinki, Finland.
- Department of Virology, Medicum, University of Helsinki, Helsinki, Finland.
- Department of Veterinary Biosciences, University of Helsinki, Helsinki, Finland.
- Biostatistics Consulting, Department of Public Health, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
ORCID-Profile: Susanna Tall, Maaret Turtinen, Anna Parviainen, Jenni Pettersson, Anna But, Jussi Hepojoki, Rommel Iheozor-Ejiofor, Hasan Uğurlu, Kalle Saksela, Suvi M Virtanen, Mikael Knip
Förderung
- Helsingin ja Uudenmaan Sairaanhoitopiiri
- Horizon 2020 Framework Programme
- Academy of Finland
- EU HERA: DURABLE
- Jane ja Aatos Erkon Säätiö
- VTR
- Sigrid Juséliuksen Säätiö
- Medicinska Understödsföreningen Liv och Hälsa
Zitieren
APA
Tall, S., Turtinen, M., Parviainen, A., Pettersson, J., But, A., Härkönen, T., Hepojoki, J., Sironen, T., Iheozor-Ejiofor, R., Uğurlu, H., Saksela, K., Ilonen, J., Virtanen, S. M., Vapalahti, O., Knip, M., & Finnish Pediatric Diabetes Register (2026). Trends in the incidence of childhood type 1 diabetes after the COVID-19 lockdown in Finland: An observational study. PLOS Medicine, 23(11), e1005288. https://doi.org/10.1371/journal.pmed.1005288
Vancouver
Tall S, Turtinen M, Parviainen A, Pettersson J, But A, Härkönen T, et al. Trends in the incidence of childhood type 1 diabetes after the COVID-19 lockdown in Finland: An observational study. PLOS Medicine. 2026;23(11):e1005288. doi:10.1371/journal.pmed.1005288
BibTeX
@article{Tall2026,
author = {Tall, Susanna and Turtinen, Maaret and Parviainen, Anna and Pettersson, Jenni and But, Anna and Härkönen, Taina and Hepojoki, Jussi and Sironen, Tarja and Iheozor-Ejiofor, Rommel and Uğurlu, Hasan and Saksela, Kalle and Ilonen, Jorma and Virtanen, Suvi M and Vapalahti, Olli and Knip, Mikael and Finnish Pediatric Diabetes Register, Finnish Pediatric Diabetes Register},
title = {Trends in the incidence of childhood type 1 diabetes after the COVID-19 lockdown in Finland: An observational study},
journal = {PLOS Medicine},
year = {2026},
volume = {23},
number = {11},
pages = {e1005288},
doi = {10.1371/journal.pmed.1005288}
}
EUVIMED